70 related articles for article (PubMed ID: 33285315)
1. The association of leukocyte immunoglobulin-like receptor subfamily B-4 expression in acute myeloid leukemia and central nervous system involvement.
Bergstrom CP; Dahiya S; Chen W; Zhang CC; Zhu H; Yan J; Madanat Y; Patel P; Vusirkala M; Ramakrishnan P; Rizvi S; Chung S; Awan F; Anderson LD; Collins R; Kansagra A
Leuk Res; 2021 Jan; 100():106480. PubMed ID: 33285315
[TBL] [Abstract][Full Text] [Related]
2. Protein Arginine Methyltransferase 5 Promotes the Migration of AML Cells by Regulating the Expression of Leukocyte Immunoglobulin-Like Receptor B4.
Zhao L; Cheng B; Xiong J; Ma D; Liu X; Wang L; Zhang X; Wang J
Biomed Res Int; 2021; 2021():7329072. PubMed ID: 34712735
[TBL] [Abstract][Full Text] [Related]
3. LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration.
Deng M; Gui X; Kim J; Xie L; Chen W; Li Z; He L; Chen Y; Chen H; Luo W; Lu Z; Xie J; Churchill H; Xu Y; Zhou Z; Wu G; Yu C; John S; Hirayasu K; Nguyen N; Liu X; Huang F; Li L; Deng H; Tang H; Sadek AH; Zhang L; Huang T; Zou Y; Chen B; Zhu H; Arase H; Xia N; Jiang Y; Collins R; You MJ; Homsi J; Unni N; Lewis C; Chen GQ; Fu YX; Liao XC; An Z; Zheng J; Zhang N; Zhang CC
Nature; 2018 Oct; 562(7728):605-609. PubMed ID: 30333625
[TBL] [Abstract][Full Text] [Related]
4. Incidence, risk factors, and outcome of asymptomatic central nervous system involvement in adult patients with acute myeloid leukemia.
Virijevic M; Kraguljac-Kurtovic N; Mitrovic M; Jakovic L; Bukumuric Z; Pantic N; Sabljic N; Pravdic Z; Cvetkovic M; Knezevic V; Dragovic-Ivancevic T; Djunić I; Rajic J; Milosevic V; Todorovic-Balint M; Vidovic A; Suvajdzic-Vukovic N
Hematol Oncol; 2024 Mar; 42(2):e3253. PubMed ID: 38536200
[TBL] [Abstract][Full Text] [Related]
5. Systematic review and meta-analysis evaluating clinical outcomes in adult acute myeloid leukemia patients with central nervous system involvement.
Goulart H; Sastow D; Moshier E; Martin L; Mascarenhas J; Tremblay D
Leuk Res; 2024 Feb; 137():107452. PubMed ID: 38335816
[TBL] [Abstract][Full Text] [Related]
6. Exclusion of Acute Myeloid Leukemia Patients with Central Nervous System Involvement from Clinical Trials: An Analysis of the National Institutes of Health Clinical Trials Registry from 2012 to 2022.
Sastow D; Van Hyfte G; Feld J; Kremyanskaya M; Mascarenhas J; Tremblay D
Acta Haematol; 2024; 147(3):292-299. PubMed ID: 37751713
[TBL] [Abstract][Full Text] [Related]
7. Fc gamma receptors promote antibody-induced LILRB4 internalization and immune regulation of monocytic AML.
Morse JW; Gui X; Deng M; Huang R; Ye X; Zhao P; Fan X; Xiong W; Zhang C; Zhang N; An Z
Antib Ther; 2024 Jan; 7(1):13-27. PubMed ID: 38235377
[TBL] [Abstract][Full Text] [Related]
8. LILRB4 Checkpoint for Immunotherapy: Structure, Mechanism and Disease Targets.
Xiang Z; Yin X; Wei L; Peng M; Zhu Q; Lu X; Guo J; Zhang J; Li X; Zou Y
Biomolecules; 2024 Feb; 14(2):. PubMed ID: 38397424
[TBL] [Abstract][Full Text] [Related]
9. Combining bioinformatics and biological detection to identify novel biomarkers for diagnosis and prognosis of pulmonary tuberculosis.
Zhao G; Luo X; Han X; Liu Z
Saudi Med J; 2020 Apr; 41(4):351-360. PubMed ID: 32291421
[TBL] [Abstract][Full Text] [Related]
10. Immune-focused multi-omics analysis of prostate cancer: leukocyte Ig-Like receptors are associated with disease progression.
Vittrant B; Bergeron A; Molina OE; Leclercq M; Légaré XP; Hovington H; Picard V; Martin-Magniette ML; Livingstone J; Boutros PC; Collins C; Fradet Y; Droit A
Oncoimmunology; 2020 Dec; 9(1):1851950. PubMed ID: 33299664
[TBL] [Abstract][Full Text] [Related]
11. Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology.
Kumar SK; Callander NS; Adekola K; Anderson L; Baljevic M; Campagnaro E; Castillo JJ; Chandler JC; Costello C; Efebera Y; Faiman M; Garfall A; Godby K; Hillengass J; Holmberg L; Htut M; Huff CA; Kang Y; Hultcrantz M; Larson S; Liedtke M; Martin T; Omel J; Shain K; Sborov D; Stockerl-Goldstein K; Weber D; Keller J; Kumar R
J Natl Compr Canc Netw; 2020 Dec; 18(12):1685-1717. PubMed ID: 33285522
[TBL] [Abstract][Full Text] [Related]
12. Murine double minute 2 inhibition alone or with cytarabine in acute myeloid leukemia: Results from an idasanutlin phase 1/1b study⋆.
Yee K; Papayannidis C; Vey N; Dickinson MJ; Kelly KR; Assouline S; Kasner M; Seiter K; Drummond MW; Yoon SS; Lee JH; Blotner S; Jukofsky L; Pierceall WE; Zhi J; Simon S; Higgins B; Nichols G; Monnet A; Muehlbauer S; Ott M; Chen LC; Martinelli G
Leuk Res; 2021 Jan; 100():106489. PubMed ID: 33302031
[TBL] [Abstract][Full Text] [Related]
13. Survival following relapse after allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes in the contemporary era.
Hong S; Rybicki L; Corrigan D; Hamilton BK; Sobecks R; Kalaycio M; Gerds AT; Dean RM; Hill BT; Pohlman B; Jagadeesh D; Anwer F; Majhail NS
Hematol Oncol Stem Cell Ther; 2021 Dec; 14(4):318-326. PubMed ID: 33301747
[TBL] [Abstract][Full Text] [Related]
14. Identifying and Characterizing a Chronic Cough Cohort Through Electronic Health Records.
Weiner M; Dexter PR; Heithoff K; Roberts AR; Liu Z; Griffith A; Hui S; Schelfhout J; Dicpinigaitis P; Doshi I; Weaver JP
Chest; 2021 Jun; 159(6):2346-2355. PubMed ID: 33345951
[TBL] [Abstract][Full Text] [Related]
15. Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy.
Carter JL; Hege K; Yang J; Kalpage HA; Su Y; Edwards H; Hüttemann M; Taub JW; Ge Y
Signal Transduct Target Ther; 2020 Dec; 5(1):288. PubMed ID: 33335095
[TBL] [Abstract][Full Text] [Related]
16. Intratumor Heterogeneity of HLA-G Expression in Cancer Lesions.
Zhang X; Lin A; Han QY; Zhang JG; Chen QY; Ye YH; Zhou WJ; Xu HH; Gan J; Yan WH
Front Immunol; 2020; 11():565759. PubMed ID: 33329527
[TBL] [Abstract][Full Text] [Related]
17. Checkpoint Blockade in Melanoma Patients With Underlying Chronic Lymphocytic Leukemia.
Smithy JW; Pianko MJ; Maher C; Postow MA; Shoushtari AN; Momtaz P; Chapman PB; Wolchok JD; Park JH; Callahan MK
J Immunother; 2021 Jan; 44(1):9-15. PubMed ID: 33290361
[TBL] [Abstract][Full Text] [Related]
18. Biologic drug survival rates in the era of anti-interleukin-17 antibodies: a time-period-adjusted registry analysis.
Graier T; Salmhofer W; Jonak C; Weger W; Kölli C; Gruber B; Sator PG; Prillinger K; Mlynek A; Schütz-Bergmayr M; Richter L; Ratzinger G; Painsi C; Selhofer S; Häring N; Wippel-Slupetzky K; Skvara H; Trattner H; Tanew A; Inzinger M; Tatarski R; Bangert C; Ellersdorfer C; Lichem R; Gruber-Wackernagel A; Hofer A; Legat F; Schmiedberger E; Strohal R; Lange-Asschenfeldt B; Schmuth M; Vujic I; Hoetzenecker W; Trautinger F; Saxinger W; Müllegger R; Quehenberger F; Wolf P
Br J Dermatol; 2021 Jun; 184(6):1094-1105. PubMed ID: 33289075
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin-Mediated Upregulation of APE2 Binding to MYH9 Provokes Mitochondrial Fragmentation and Acute Kidney Injury.
Hu Y; Yang C; Amorim T; Maqbool M; Lin J; Li C; Fang C; Xue L; Kwart A; Fang H; Yin M; Janocha AJ; Tsuchimoto D; Nakabeppu Y; Jiang X; Mejia-Garcia A; Anwer F; Khouri J; Qi X; Zheng QY; Yu JS; Yan S; LaFramboise T; Anderson KC; Herlitz LC; Munshi NC; Lin J; Zhao J
Cancer Res; 2021 Feb; 81(3):713-723. PubMed ID: 33288657
[TBL] [Abstract][Full Text] [Related]
20. NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021.
von Mehren M; Kane JM; Bui MM; Choy E; Connelly M; Dry S; Ganjoo KN; George S; Gonzalez RJ; Heslin MJ; Homsi J; Keedy V; Kelly CM; Kim E; Liebner D; McCarter M; McGarry SV; Meyer C; Pappo AS; Parkes AM; Paz IB; Petersen IA; Poppe M; Riedel RF; Rubin B; Schuetze S; Shabason J; Sicklick JK; Spraker MB; Zimel M; Bergman MA; George GV
J Natl Compr Canc Netw; 2020 Dec; 18(12):1604-1612. PubMed ID: 33285515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
